{
    "Trade/Device Name(s)": [
        "CareSens S Fit Blood Glucose Monitoring System",
        "CareSens S Blood Glucose Test Strips",
        "CareSens S Glucose Control Solution"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K180866",
    "Predicate Device Reference 510(k) Number(s)": [
        "K170614"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "August 31, 2018",
    "Summary Letter Received Date": "April 2, 2018",
    "Submission Date": "March 26, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CareSens S Fit Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technology",
        "Amperometric method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for CareSens S Fit Blood Glucose Monitoring System utilizing electrochemical biosensor technology for self-monitoring glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the fingertip for self-testing at home by people with diabetes to monitor effectiveness of diabetes control; not for neonates, diagnosis, or screening of diabetes.",
    "fda_folder": "Clinical Chemistry"
}